Alzheimer’s Disease And Dementia – Johns Hopkins Medicine Podcasts

When it comes to slowing down cognitive decline in those with early Alzheimer’s disease a total package of lifestyle interventions is superior to currently available medications, a study by Johns Hopkins neurologist Majid Fotuhi has shown. Fotuhi and colleagues had …

Does a program exist to implement comprehensive lifestyle changes to preserve cognitive function? Elizabeth Tracey reports Read more →

If you have mild cognitive impairment or early Alzheimer’s disease, changes in lifestyle are more likely to provide benefit to your cognitive capacity than available medicines, a study by Johns Hopkins neurologist Majid Fotuhi shows. Fotuhi says this is largely …

How exactly do lifestyle interventions benefit brain health? Elizabeth Tracey reports Read more →

Lifestyle interventions are more effective than medications in early Alzheimer’s disease, a study led by Majid Fotuhi, a neurologist at Johns Hopkins, has found. When a number of trials were analyzed together, implementation of several lifestyle changes emerged as superior …

Comprehensive lifestyle changes impact wellbeing in those with early Alzheimer’s disease, Elizabeth Tracey reports Read more →

Declines of several fold in rates of progression- sounds pretty good, doesn’t it, if you have the beginning stages of Alzheimer’s disease and are considering available medications. Yet a recent study by Johns Hopkins neurologist Majid Fotuhi finds that those …

How is it that medications to treat Alzheimer’s disease appear to show such a benefit? Elizabeth Tracey reports Read more →

Comprehensive lifestyle changes are better than medications to slow, stop or even improve mild cognitive impairment or early Alzheimer’s disease, a study by Johns Hopkins neurologist Majid Fotuhi finds. This meta analysis of existing randomized trials sought to compare the …

If you’ve been diagnosed with mild cognitive impairment what’s the best strategy to slow decline? Elizabeth Tracey reports Read more →

Brain organoids, collections of cells found in the brain, have been grown from blood samples of people with Alzheimer’s disease and used to assess the impact of a drug called escitalopram in a new study. Vasiliki Machairaki, study leader and …

A model of your brain may one day be grown in a lab, Elizabeth Tracey reports Read more →

Extracellular vesicles are membrane bound packages cells use to jettison materials from inside the cell, a sort of trash can. Johns Hopkins genetic medicine expert Vasiliki Machairaki has shown in a new study that these vesicles may be a means …

What can be learned from what cells dispose of? Elizabeth Tracey reports Read more →

What might a model of the hindbrain, which helps control functions like sleep, breathing and heart rate, tell us about using a common depression drug in people with Alzheimer’s disease? Genetic medicine expert Vasiliki Machairaki at Johns Hopkins says her …

Brain organoids can resemble specific parts of the brain, Elizabeth Tracey reports Read more →

Drugs to manage symptoms of Alzheimer’s disease may work in some people but not in others. Now a new method using brain organoids, which are derived from a person’s own blood sample, may help determine whether a specific medication is …

Can drugs to manage Alzheimer’s disease be tested in organoids? Elizabeth Tracey reports Read more →

Brain organoids are lab grown clusters of cells that have several of the cell types found in someone’s brain. Cells taken from a person’s blood are coaxed to become stem cells, then differentiate into brain cells. Vasiliki Machairaki, a genetic …

Can brain organoids help in treating people with Alzheimer’s disease? Elizabeth Tracey reports Read more →